Cargando…

Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis

Detalles Bibliográficos
Autores principales:	John, Binu V., Sidney Barritt, A., Moon, Andrew, Taddei, Tamar H., Kaplan, David E., Dahman, Bassam, Doshi, Akash, Deng, Yangyang, Mansour, Natalie, Ioannou, George, Martin, Paul, Chao, Hann-Hsiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	W.B. Saunders for the American Gastroenterological Association 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212810/ https://www.ncbi.nlm.nih.gov/pubmed/35716904 http://dx.doi.org/10.1016/j.cgh.2022.05.038

Ejemplares similares

Effectiveness of COVID-19 viral vector vaccine Ad.26.COV2.S vaccine and comparison with mRNA vaccines in patients with cirrhosis
por: John, Binu, et al.
Publicado: (2022)

Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS
por: John, Binu V., et al.
Publicado: (2022)

782: COMPARISON OF INFECTION-INDUCED AND VACCINE-INDUCED IMMUNITY AGAINST CORONAVIRUS 2019 IN PATIENTS WITH CIRRHOSIS
por: John, Binu V., et al.
Publicado: (2022)

Effectiveness of mRNA vaccines in patients with cirrhosis with rising prevalence of SARS-CoV-2 delta variant
por: John, Binu, et al.
Publicado: (2022)

Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis
por: John, Binu V., et al.
Publicado: (2022)

Coronavirus Disease 2019 Vaccination Is Associated With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Death in Liver Transplant Recipients
por: John, Binu V., et al.
Publicado: (2022)

Impact of Obeticholic acid Exposure on Decompensation and Mortality in Primary Biliary Cholangitis and Cirrhosis
por: John, Binu V., et al.
Publicado: (2021)

Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis
por: Ferreira, Raphaella D., et al.
Publicado: (2022)

Reply
por: John, Binu V., et al.
Publicado: (2022)

Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: case report
por: Naghashzadeh, Farah, et al.
Publicado: (2022)

Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19
por: Corchado-Garcia, Juan, et al.
Publicado: (2021)

Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination
por: Ujueta, Francisco, et al.
Publicado: (2021)

Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species
por: Zahn, Roland, et al.
Publicado: (2012)

Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination
por: Kemper, Marcel, et al.
Publicado: (2021)

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
por: Muir, Kate-Lynn, et al.
Publicado: (2021)

Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma
por: Aitcheson, Gabriella, et al.
Publicado: (2021)

Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines
por: Michalik, Stephan, et al.
Publicado: (2022)

Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment()
por: Custers, Jerome, et al.
Publicado: (2021)

Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination
por: Gelbenegger, Georg, et al.
Publicado: (2021)

Guillain-Barré Syndrome After Ad26.COV2.S Vaccination
por: Thant, Hein Linn, et al.
Publicado: (2022)

Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination
por: Bova, Carlo, et al.
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination
por: Yocum, Andrew, et al.
Publicado: (2021)

Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S
por: Huynh, Angela, et al.
Publicado: (2022)

Allergic reactions to the Ad26.COV2.S vaccine in South Africa
por: Peter, Jonny, et al.
Publicado: (2021)

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
por: Maxfield, Lori F., et al.
Publicado: (2015)

Who Treats Patients with Diabetes and Compensated Cirrhosis
por: Liu, Tsai-Ling, et al.
Publicado: (2016)

Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine
por: Schmidt, Katja G., et al.
Publicado: (2023)

Correction: Who Treats Patients with Diabetes and Compensated Cirrhosis
por: Liu, Tsai-Ling, et al.
Publicado: (2018)

Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study
por: Takuva, Simbarashe, et al.
Publicado: (2021)

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
por: Sablerolles, Roos S.G., et al.
Publicado: (2022)

Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccine
por: Sowell, Josiah, et al.
Publicado: (2021)

Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection
por: Montefiori, David C.
Publicado: (2022)

In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge
por: Moon, Andrew M., et al.
Publicado: (2020)

Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines
por: Hwang, Jimin, et al.
Publicado: (2021)

The association between mental illness and all-cause mortality in patients with cirrhosis: a Veterans Affairs retrospective cohort study
por: Shaffer, Lauren R., et al.
Publicado: (2023)

Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination
por: Kulkarni, Prathit A., et al.
Publicado: (2021)

Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male
por: Hussain, Habiba, et al.
Publicado: (2021)

Reply to “Widespread Cutaneous Reaction to the Johnson & Johnson Ad26.Cov2.S Vaccine”
por: Malachowski, Stephen J., et al.
Publicado: (2022)

Widespread annular eruption after Ad26.COV2.S COVID-19 vaccine
por: Song, Eingun James, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mkrvj29vslon35qmr7u5qtj910